| Impaired dopamine metabolism in Parkinson’s disease pathogenesis A Masato, N Plotegher, D Boassa, L Bubacco Molecular neurodegeneration 14 (1), 35, 2019 | 317 | 2019 |
| Parkinson’s disease–associated LRRK2 interferes with astrocyte-mediated alpha-synuclein clearance L Streubel-Gallasch, V Giusti, M Sandre, I Tessari, N Plotegher, E Giusto, ... Molecular Neurobiology 58, 3119-3140, 2021 | 87 | 2021 |
| Metformin repurposing for Parkinson disease therapy: opportunities and challenges F Agostini, A Masato, L Bubacco, M Bisaglia International journal of molecular sciences 23 (1), 398, 2021 | 50 | 2021 |
| DOPAL initiates αSynuclein-dependent impaired proteostasis and degeneration of neuronal projections in Parkinson’s disease A Masato, N Plotegher, F Terrin, M Sandre, G Faustini, A Thor, S Adams, ... npj Parkinson's Disease 9 (1), 42, 2023 | 28 | 2023 |
| Synapsin III gene silencing redeems alpha-synuclein transgenic mice from Parkinson's disease-like phenotype G Faustini, F Longhena, A Masato, V Bassareo, R Frau, T Klingstedt, ... Molecular Therapy 30 (4), 1465-1483, 2022 | 17 | 2022 |
| Photoresponsive Prion‐Mimic Foldamer to Induce Controlled Protein Aggregation G Marafon, M Crisma, A Masato, N Plotegher, L Bubacco, A Moretto Angewandte Chemie 133 (10), 5233-5238, 2021 | 16 | 2021 |
| Patients stratification strategies to optimize the effectiveness of scavenging biogenic aldehydes: towards a neuroprotective approach for Parkinson's disease A Masato, M Sandre, A Antonini, L Bubacco Current Neuropharmacology 19 (10), 1618, 2021 | 12 | 2021 |
| Too much for your own good: Excessive dopamine damages neurons and contributes to Parkinson's disease: An Editorial Highlight for “Enhanced tyrosine hydroxylase activity … A Masato, L Bubacco, E Greggio Journal of Neurochemistry 158 (4), 833-836, 2021 | 7 | 2021 |
| Superoxide dismutases SOD1 and SOD2 rescue the toxic effect of dopamine-derived products in human SH-SY5Y neuroblastoma cells A Biosa, F De Lazzari, A Masato, R Filograna, N Plotegher, M Beltramini, ... Neurotoxicity Research 36, 746-755, 2019 | 7 | 2019 |
| SARS-CoV-2-Mimicking Pseudoviral Particles Accelerate α-Synuclein Aggregation In Vitro G Zilio, A Masato, M Sandre, A Caregnato, F Moret, AK Maciola, ... ACS Chemical Neuroscience 15 (2), 215-221, 2023 | 5 | 2023 |
| Scavenging neurotoxic aldehydes using lysine carbon dots DN Bloch, M Sandre, SB Zichri, A Masato, S Kolusheva, L Bubacco, ... Nanoscale Advances 5 (5), 1356-1367, 2023 | 5 | 2023 |
| A SPLICS reporter reveals α-synuclein regulation of lysosome-mitochondria contacts which affects TFEB nuclear translocation F Giamogante, L Barazzuol, F Maiorca, E Poggio, A Esposito, A Masato, ... Nature Communications 15 (1), 1516, 2024 | 3 | 2024 |
| DOPAL initiates αSynuclein-mediated impaired proteostasis in neuronal projections leading to enhanced vulnerability in Parkinson’s disease A Masato, N Plotegher, A Thor, S Adams, M Sandre, S Cogo, F De Lazzari, ... BioRxiv, 2021.06. 15.448476, 2021 | 3 | 2021 |
| Sequestosome-1 (SQSTM1/p62) as a target in dopamine catabolite-mediated cellular dyshomeostasis A Masato, A Andolfo, G Favetta, EN Bellini, S Cogo, L Dalla Valle, ... Cell Death & Disease 15 (6), 424, 2024 | 1 | 2024 |
| Neuroprotective Effect of Antiapoptotic URG7 Protein on Human Neuroblastoma Cell Line SH-SY5Y I Nigro, R Miglionico, M Carmosino, A Gerbino, A Masato, M Sandre, ... International Journal of Molecular Sciences 25 (1), 481, 2023 | 1 | 2023 |
| The αSynuclein half-life conundrum A Masato, L Bubacco Neurobiology of Disease, 106524, 2024 | | 2024 |
| morbo di Parkinson C si sono formati gli Appennini, U ricerca pubblicata su Tectonics Minerva, 2024 | | 2024 |
| Synaptic Release of Pathological Tau Is Calcium-and SNAP25-Dependent, and Blocked by BoNT-A Activity A Masato, C Panzi, I Butnaru, L Restani, F Mazzo, E Sher, S Bose, ... Toxicon 237, 107450, 2024 | | 2024 |
| Parkinson's Disease-Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance V Giusti, L Streubel-Gallasch, M Sandre, I Tessari, N Plotegher, E Giusto, ... GLIA 69, E211-E212, 2021 | | 2021 |
| Altered dopamine metabolism leads to a unique impaired alpha Synuclein proteostasis in Parkinson's Disease. A Masato, F De Lazzari, M Madany, A Thor, M Bisaglia, E Greggio, ... ACTA PHYSIOLOGICA 227, 2-3, 2019 | | 2019 |